Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $0.78, in-line with the analyst estimate of $0.78. Revenue for the quarter came in at $5.38 billion versus the consensus estimate of $5.32 billion.Eli Lilly & Co. reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.